MDCO-216 Does Not Induce Adverse Immunostimulation, in Contrast to Its Predecessor ETC-216.

about

HDL Mimetics Infusion and Regression of Atherosclerosis: Is It Still Considered a Valid Therapeutic Option?

P2860

Q55257404-C277EAC3-8176-4F31-AF84-CF56CB127CA6

P2860

MDCO-216 Does Not Induce Adverse Immunostimulation, in Contrast to Its Predecessor ETC-216.

Item

http://www.wikidata.org/entity/Q38606925

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

MDCO-216 Does Not Induce Adver ...... st to Its Predecessor ETC-216.

@en

type

Item

label

MDCO-216 Does Not Induce Adver ...... st to Its Predecessor ETC-216.

@en

prefLabel

MDCO-216 Does Not Induce Adver ...... st to Its Predecessor ETC-216.

@en

P1476

MDCO-216 Does Not Induce Adver ...... st to Its Predecessor ETC-216.

@en

P2093

D G Kallend

http://www.w3.org/2001/XMLSchema#string

J Burggraaf

http://www.w3.org/2001/XMLSchema#string

J W Jukema

http://www.w3.org/2001/XMLSchema#string

Joannes A A Reijers

http://www.w3.org/2001/XMLSchema#string

K E Malone

http://www.w3.org/2001/XMLSchema#string

M Moerland

http://www.w3.org/2001/XMLSchema#string

P L J Wijngaard

http://www.w3.org/2001/XMLSchema#string

P2860

A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family

Pro- or anti-inflammatory role of apolipoprotein A-1 in high-density lipoproteins?

Recombinant pharmaceuticals from microbial cells: a 2015 update

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

Evaluation of the in vitro pyrogen test system based on proinflammatory cytokine release from human monocytes: comparison with a human whole blood culture test system and with the rabbit pyrogen test.

Basic science review: Statin therapy--Part I: The pleiotropic effects of statins in cardiovascular disease.

Overview of bacterial expression systems for heterologous protein production: from molecular and biochemical fundamentals to commercial systems.

A single infusion of MDCO-216 (ApoA-1 Milano/POPC) increases ABCA1-mediated cholesterol efflux and pre-beta 1 HDL in healthy volunteers and patients with stable coronary artery disease.

Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis.

Use of toll-like receptor assays to detect and identify microbial contaminants in biological products.

P31

scholarly article

P356

10.1007/S10557-017-6746-X

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28844118

http://www.w3.org/2001/XMLSchema#string

P932

5591804

http://www.w3.org/2001/XMLSchema#string

MDCO-216 Does Not Induce Adverse Immunostimulation, in Contrast to Its Predecessor ETC-216.

about

P2860

P2860

MDCO-216 Does Not Induce Adverse Immunostimulation, in Contrast to Its Predecessor ETC-216.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P577

P698

P932